In the Hot Seat: Tracey Skinner, Airmic chair

In the Hot Seat: Tracey Skinner, Airmic chair

In the Hot Seat: Tracey Skinner, Airmic chair

Tracey Skinner, group insurance director at BT Group, the UK telecommunications group, has long been an active member of Airmic and has accepted the role of chair of the association in what will inevitably prove to be a busy and challenging year for members of the UK risk management community, as they help their companies emerge from lockdown. Adrian Ladbury…

Crisis breathes new life into Airmic’s SIG programme

Crisis breathes new life into Airmic’s SIG programme

Crisis breathes new life into Airmic’s SIG programme

Airmic has run special interest groups (SIGs) for many years to help members dig deeper into areas of particular importance by both sector and topics. It makes a lot of sense. Risk and insurance managers of course work for all sorts of companies in the myriad of different sectors and have as many job descriptions as there are members. No…

Learning lessons from Covid-19

Learning lessons from Covid-19

Learning lessons from Covid-19

With more than 100 years since the last global pandemic, it is not surprising that words like “unprecedented” are being used to describe the current coronavirus crisis, according to Claire McDonald, UK and Ireland country manager for Risk Frontiers Europe sponsor HDI Global. “It’s beyond our collective consciousness,” she says. “We have slightly reworked history. You may have heard people…

UK court issues warning on human rights violations in Sierra Leone

UK court issues warning on human rights violations in Sierra Leone

UK court issues warning on human rights violations in Sierra Leone

Risk managers are advised to take a cautious approach as the UK Court of Appeal decision in the African Minerals case serves as a warning to companies engaging third parties when operating abroad, particularly in countries with poor human rights records. It also highlights the trend (on which we have reported before) for such cases to be brought before the…

Back to the future

Back to the future

Back to the future

Roscoe Fawcett of Bridge Insurance Brokers, a UK partner of Risk Frontiers Europe sponsor Brokerslink, suggests that a little like the fairytale of The Boy Who Cried Wolf, the Covid-19 pandemic caught people unawares because previous threats had not evolved into truly global events. Liz Booth [LB]: Were you surprised at how unprepared the world was for this pandemic, given…

Risk managers showing their value through Covid-19 crisis

Risk managers showing their value through Covid-19 crisis

Risk managers showing their value through Covid-19 crisis

Continuity is the key to success with Covid-19, Chris Staes of HDI Global being prepared and able to provide clients with business continuity when it comes to insurance requirements was essential in the early days of the Covid-19 crisis. The key to that, says Chris Staes, Belgium country manager of Risk Frontiers Europe sponsor HDI Global, was providing continuity to…

A world of risk

A world of risk

A world of risk

Pandemic risk has been underestimated for many years but the interconnectedness of global trade has made it all but impossible to successfully prepare for the threat, suggests Filip Frans, director of non-life at Van Dessel Insurance Broker in Belgium, a partner of Risk Frontiers Europe sponsor Brokerslink “As with other problems, people thought they would stay local problems and would…

Cat among the pigeons

Cat among the pigeons

Cat among the pigeons

Brokers are not enjoying a great time currently, with questions raised again about conflicts of interest, inadequate transparency and the value that mega groups bring to the table for customers. Steve McGill has launched London-based international specialty broker McGill and Partners and vows to break the mould, especially in the larger corporate space. Commercial Risk Europe editorial director Adrian Ladbury…

Bayer settlement is not the end of glyphosate litigation

Bayer settlement is not the end of glyphosate litigation

Bayer settlement is not the end of glyphosate litigation

In a bold move that is hoped to bring some finality to mounting claim numbers, Bayer recently announced it will pay up to $10.9bn to settle the majority of the estimated 125,000 claims alleging Roundup caused their non-Hodgkin’s lymphoma. However, this may not be the end of a story with plenty of lessons for risk managers. Since litigation began a…

1 2 3 30